Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2005-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.0503942102PMID 16236727PMCID PMC1276049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.

  2005cited by this paper
• Amino-terminal parathyroid hormone fragment analogs containing alpha,alpha-di-alkyl amino acids at positions 1 and 3.

  2004cited by this paper
• Novel Single Chain cAMP Sensors for Receptor-induced Signal Propagation*♦

  2004cited by this paper
• Amino‐Terminal Parathyroid Hormone Fragment Analogs Containing α,α‐di‐alkyl Amino Acids at Positions 1 and 3

  2004cited by this paper
• Parathyroid hormone: a double-edged sword for bone metabolism.

  2004cited by this paper
• Realistic protein–protein association rates from a simple diffusional model neglecting long‐range interactions, free energy barriers, and landscape ruggedness

  2004cited by this paper
• Measurement of the millisecond activation switch of G protein–coupled receptors in living cells

  2003cited by this paper
• Internalization Determinants of the Parathyroid Hormone Receptor Differentially Regulate β-Arrestin/Receptor Association*

  2002cited by this paper
• Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and beta-arrestins.

  2002cited by this paper
• Enhanced activity in parathyroid hormone-(1-14) and -(1-11): novel peptides for probing ligand-receptor interactions.

  2001cited by this paper
• Evaluating the Signal Transduction Mechanism of the Parathyroid Hormone 1 Receptor

  2001cited by this paper
• Molecular properties of the PTH/PTHrP receptor.

  2001cited by this paper
• Parathyroid Hormone (PTH)-(1–14) and -(1–11) Analogs Conformationally Constrained by α-Aminoisobutyric Acid Mediate Full Agonist Responses via the Juxtamembrane Region of the PTH-1 Receptor*

  2001cited by this paper
• The Neurokinin A Receptor Activates Calcium and cAMP Responses through Distinct Conformational States*

  2001cited by this paper
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

  2001cited by this paper
• Minimization of Parathyroid Hormone

  2000cited by this paper
• Receptors for PTH and PTHrP: their biological importance and functional properties.

  1999cited by this paper
• The (1-14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors.

  1999cited by this paper
• Agonist-stimulated phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein.

  1995cited by this paper
• Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding.

  1994cited by this paper
• Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

  1992cited by this paper
• A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.

  1991cited by this paper
• Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

  1981cited by this paper
• Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction kinetic data.

  1975cited by this paper
• Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity.

  1973cited by this paper

• Parathyroid hormone receptors in GtoPdb v.2025.3

  2025cites this paper
• Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application

  2025cites this paper
• Characterization of the Two-Domain Peptide Binding Mechanism of the Human CGRP Receptor for CGRP and the Ultrahigh Affinity ssCGRP Variant

  2025cites this paper
• Key Interaction Changes Determine the Activation Process of Human Parathyroid Hormone Type 1 Receptor.

  2025cites this paper
• Insights into the structural dynamics of the secretin family (class B1) G protein-coupled receptors

  2025cites this paper
• Computational assessment of the dimeric incretin GLP-1cpGLP-1 reveals the structural bases for its activity.

  2025cites this paper
• Fast-diffusing receptor collisions with slow-diffusing peptide ligand assemble the ternary parathyroid hormone–GPCR–arrestin complex

  2024cites this paper
• The Intricacies of Renal Phosphate Reabsorption—An Overview

  2024cites this paper
• Exploring GPCR conformational dynamics using single-molecule fluorescence.

  2024cites this paper
• Highly biased agonism for GPCR ligands via nanobody tethering

  2024cites this paper
• Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor

  2023cites this paper
• Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2 G protein-coupled receptor

  2023cites this paper
• Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis

  2023cites this paper
• Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2 G protein–coupled receptor

  2023cites this paper
• Molecular insights into peptide agonist engagement with the PTH receptor.

  2023cites this paper
• A tool kit of highly selective and sensitive genetically encoded neuropeptide sensors

  2023cites this paper
• Highly biased agonism for GPCR ligands via nanobody tethering

  2023cites this paper
• Parathyroid hormone receptors in GtoPdb v.2023.1

  2023influential citation
• Molecular Mechanisms of PTH/PTHrP class B GPCR Signaling and Pharmacological Implications.

  2022cites this paper
• Endogenous ligand recognition and structural transition of a human PTH receptor.

  2022cites this paper
• New Insights into the Structure and Function of Class B1 GPCRs

  2022cites this paper
• Functional modulation of PTH1R activation and signaling by RAMP2

  2022cites this paper
• Kinetic and Thermodynamic Insights into Agonist Interactions with the Parathyroid Hormone Receptor-1 from a New NanoBRET Assay.

  2022cites this paper
• Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor

  2022cites this paper
• Structural pharmacology of PTH and PTHrP.

  2022cites this paper
• Molecular insights into peptide agonist engagement with the PTH1 receptor

  2022cites this paper
• Altered signaling at the PTH receptor via modified agonist contacts with the extracellular domain provides a path to prolonged agonism in vivo

  2022cites this paper
• Parathyroid hormone receptors in GtoPdb v.2021.3

  2021cites this paper
• Roles of Parathyroid Hormone-Related Protein (PTHrP) and Its Receptor (PTHR1) in Normal and Tumor Tissues: Focus on Their Roles in Osteosarcoma

  2021cites this paper
• A general method for quantifying ligand binding to unmodified receptors using Gaussia luciferase

  2021cites this paper
• Glucagon‐Like Peptide‐1 Receptor Activators

  2021cites this paper
• Exploring Ligand Binding to Calcitonin Gene-Related Peptide Receptors

  2021cites this paper
• Proteolytic Cleavage of the Extracellular Domain Affects Signaling of Parathyroid Hormone 1 Receptor

  2021influential citation
• PTHR1 Genetic Polymorphisms Are Associated with Osteoporosis among Postmenopausal Arab Women

  2021cites this paper
• Structural and Functional Diversity among Agonist-Bound States of the GLP-1 Receptor

  2021cites this paper
• Functional modulation of PTH1R activation and signalling by RAMP2

  2021cites this paper
• Parathyroid hormone receptors in GtoPdb v.2021.2

  2021cites this paper
• Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor Receptors.

  2020cites this paper
• Fluxes for Unraveling Complex Binding Mechanisms.

  2020cites this paper
• Drug discovery approaches targeting the incretin pathway.

  2020cites this paper
• Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4

  2020cites this paper
• Allosteric interactions in the parathyroid hormone GPCR–arrestin complex formation

  2020cites this paper
• Structural basis for allosteric modulation of class B GPCRs

  2020cites this paper
• Mechanisms of adhesion G protein–coupled receptor activation

  2020cites this paper
• Capturing Peptide–GPCR Interactions and Their Dynamics

  2020cites this paper
• Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.

  2020cites this paper
• Functional Analysis of PTH1R Variants Found in Primary Failure of Eruption

  2020cites this paper
• Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding

  2019cites this paper
• Structure and dynamics of the active human parathyroid hormone receptor-1

  2019cites this paper
• Parathyroid hormone initiates dynamic NHERF1 phosphorylation cycling and conformational changes that regulate NPT2A-dependent phosphate transport

  2019influential citation
• Biased Receptor Signaling in Drug Discovery

  2019cites this paper
• Cryo-EM structure of parathyroid hormone receptor type 1 in complex with a long-acting parathyroid hormone analog and G protein

  2019cites this paper
• Molecular Mechanisms of Parathyroid Hormone Type 1 Receptor Signaling

  2019cites this paper
• Parathyroid hormone receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• New views into class B GPCRs from the crystal structure of PTH1R

  2019cites this paper
• PTH/PTHrP Receptor Signaling, Allostery, and Structures.

  2019cites this paper
• Cryo-EM structure of the human PAC1 receptor coupled to an engineered heterotrimeric G protein

  2019cites this paper
• Functional dissection of the N-terminal extracellular domains of Frizzled 6 reveals their roles for receptor localization and Dishevelled recruitment

  2018cites this paper
• Neuropeptides as Ligands for GPCRs

  2018cites this paper
• Receptor selectivity from minimal backbone modification of a polypeptide agonist

  2018influential citation
• High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist

  2018cites this paper
• Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis

  2018cites this paper
• Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.

  2018cites this paper
• Current understanding of the structure and function of family B GPCRs to design novel drugs

  2018cites this paper
• Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism

  2018cites this paper
• GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release

  2017cites this paper
• GPCR Signaling and Trafficking: The Long and Short of It.

  2017cites this paper
• Family B G Protein-coupled Receptors and their Ligands: From Structure to Function.

  2017cites this paper
• Temporal Bias: Time-Encoded Dynamic GPCR Signaling.

  2017cites this paper
• High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH2) receptor requires the hydroxyl group of Tyr-318 on transmembrane helix 5

  2017cites this paper
• Cryo-EM structure of the activated GLP-1 receptor in complex with G protein

  2017cites this paper
• GIP(3–30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP‐mediated insulin, glucagon, and somatostatin release

  2017cites this paper
• Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity.

  2017cites this paper
• Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution.

  2017cites this paper
• A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A3 Receptor in Living Cells

  2017cites this paper
• Small Molecule Inhibited Parathyroid Hormone Mediated cAMP Response by N–Terminal Peptide Binding

  2016cites this paper
• On the different experimental manifestations of two‐state ‘induced‐fit’ binding of drugs to their cellular targets

  2016cites this paper
• Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor*

  2016cites this paper
• Sorting nexin 27 couples PTHR trafficking to retromer for signal regulation in osteoblasts during bone growth

  2016cites this paper
• Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors*

  2016cites this paper
• PTH and Vitamin D.

  2016cites this paper
• Chapter 56 – Parathyroid Hormone and the Parathyroid Hormone Receptor Type 1 in the Regulation of Calcium and Phosphate Homeostasis and Bone Metabolism

  2016cites this paper
• Title Structure-Activity Relationship Studies of Nand C-TerminallyModified Secretin Analogs for the Human Secretin Receptor

  2016cites this paper
• A Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor.

  2016cites this paper
• Resonance Energy Transfer-Based Approaches to Study GPCRs.

  2016cites this paper
• Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

  2015cites this paper
• Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2‐adrenoceptor

  2015cites this paper
• The non‐peptide GLP‐1 receptor agonist WB4‐24 blocks inflammatory nociception by stimulating β‐endorphin release from spinal microglia

  2015cites this paper
• Ligand Residence Time at G-protein–Coupled Receptors—Why We Should Take Our Time To Study It

  2015cites this paper
• Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia.

  2015cites this paper
• Ligand residence time at GPCRs – why we should take our time to study

  2015influential citation
• On the ‘micro’-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action

  2015cites this paper
• The Role of Binding Kinetics in GPCR Drug Discovery.

  2015cites this paper
• Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin.

  2015cites this paper
• Probing the pharmacology of G protein-coupled receptors with fluorescent ligands.

  2015cites this paper
• Ligand Binding Pocket Formed by Evolutionarily Conserved Residues in the Glucagon-like Peptide-1 (GLP-1) Receptor Core Domain*

  2015cites this paper
• Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.

  2015cites this paper
• PTH receptor-1 signalling—mechanistic insights and therapeutic prospects

  2015cites this paper
• Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors.

  2014cites this paper
• Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

  2014cites this paper